Antibacterial effect of silver nanoparticles on Staphylococcus aureus

被引:235
作者
Mirzajani, Fateme [1 ]
Ghassempour, Alireza [1 ]
Aliahmadi, Atousa [2 ,3 ]
Esmaeili, Mohammad Ali [2 ]
机构
[1] Shahid Beheshti Univ, Med Plants & Drugs Res Inst, Dept Phytochem, Tehran, Iran
[2] Shahid Beheshti Univ, Med Plants & Drugs Res Inst, Dept Biol, Tehran, Iran
[3] Univ Isfahan, Fac Sci, Dept Biol, Esfahan, Iran
关键词
Antibactericidal mechanism; Muramic acid; Peptidoglycan; Silver nanoparticles; Staphylococcus aureus; ESCHERICHIA-COLI; MURAMIC ACID; ION; NANOSILVER; MECHANISM; TOXICITY;
D O I
10.1016/j.resmic.2011.04.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antibacterial activity of silver nanoparticles (AgNPs) was investigated using Staphylococcus aureus PTCC1431 as a model of Gram-positive bacteria. The mechanism of antibacterial activity of AgNPs was then studied by analyzing the growth, morphology, and molecular variations in the cell wall. Experimental data showed that AgNPs at a concentration of 4 mu g/ml completely inhibited bacterial growth. Transmission electron microscopy results confirmed cell wall damage produced by AgNPs as well as accumulation of AgNPs in the bacterial membrane. Meanwhile, the AgNP-treated bacteria were monitored by circular dichroism to reveal peptidoglycan variations. Some degree of variation in the alpha-helix position of the peptide chain was observed. Moreover, increasing the AgNP concentration to 8 mu g/ml resulted in release of muramic acid (MA) into the medium, which could be attributed to cell wall distraction. A gas chromatography-tandem mass spectrometry analysis and release of MA, as a bacterial indicator, showed that glycan strands may also be decomposed as a result of AgNP treatment. (C) 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:542 / 549
页数:8
相关论文
共 32 条
[1]   ADHERENCE OF ORGANISMS TO SILVER-COATED SURFACES [J].
AHEARN, DG ;
MAY, LL ;
GABRIEL, MM .
JOURNAL OF INDUSTRIAL MICROBIOLOGY, 1995, 15 (04) :372-376
[2]   Toxicity of silver nanoparticles in zebrafish models [J].
Asharani, P. V. ;
Wu, Yi Lian ;
Gong, Zhiyuan ;
Valiyaveettil, Suresh .
NANOTECHNOLOGY, 2008, 19 (25)
[3]   Structure of muramic acid TMS derivative mass spectrum's base ion (m/z=185) used for quantification of bacterial peptidoglycan [J].
Bal, K ;
Larsson, L ;
Mielniczuk, E ;
Mielniczuk, Z .
JOURNAL OF MICROBIOLOGICAL METHODS, 2002, 48 (2-3) :267-270
[4]  
Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1
[5]   Nanosilver: A nanoproduct in medical application [J].
Chen, X. ;
Schluesener, H. J. .
TOXICOLOGY LETTERS, 2008, 176 (01) :1-12
[6]   Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria [J].
Choi, Okkyoung ;
Hu, Zhiqiang .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2008, 42 (12) :4583-4588
[7]   Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae [J].
Dibrov, P ;
Dzioba, J ;
Gosink, KK ;
Häse, CC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2668-2670
[8]   Synthesis and optical properties of silver nanoparticles and arrays [J].
Evanoff, DD ;
Chumanov, G .
CHEMPHYSCHEM, 2005, 6 (07) :1221-1231
[9]   Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria [J].
Fayaz, Amanulla Mohammed ;
Balaji, Kulandaivelu ;
Girilal, Morukattu ;
Yadav, Ruchi ;
Kalaichelvan, Pudupalayam Thangavelu ;
Venketesan, Ramasamy .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2010, 6 (01) :103-109
[10]  
Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO